Molecular Biology Enzymes Comprehensive Study by Type (Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Phosphatases, Proteases and Proteinases, Other Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology, Other Applications), End users (Academic & Research Institutes, Pharmaceutical & Biotechnology companies, Hospitals & Diagnostic Centers) Players and Region - Global Market Outlook to 2030

Molecular Biology Enzymes Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 14.5%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Molecular Biology Enzymes
Molecular Biology Enzymes are biocatalysts which are produced by animals, plants and bacteria and are used for optimizing the workflow. These are used to produce the consumables and used by biotechnology and pharmaceutical sector. Additionally, molecular biology enzyme is used to detect the amount of glucose in the blood and other applications such as research and development. These factors are fueling the market growth.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR14.5%


In this market of molecular biology enzymes the players are looking to offer a portfolio of diagnostics assays to hospitals, clinics, and pathology laboratories. The factors such as rising research and developments is propelling the market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Molecular Biology Enzymes market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific (United States), Merck (United States), New England Biolabs (United States), Promega (United States), Illumina (United States), Agilent Technologies (United States), F. Hoffmann-la Roche (Switzerland), Takara Bio (Japan), QIAGEN N.V. (Germany), Becton Dickinson (United States) and Creative Enzymes (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Sunsun (China) and Toyobo (Japan).

Segmentation Overview
AMA Research has segmented the market of Global Molecular Biology Enzymes market by Type (Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Phosphatases, Proteases and Proteinases and Other Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology and Other Applications) and Region.



On the basis of geography, the market of Molecular Biology Enzymes has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End users, the sub-segment i.e. Academic & Research Institutes will boost the Molecular Biology Enzymes market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological advancements in life sciences and Rising implementation of biotechnology

Market Growth Drivers:
Rising usage of protein and reagents in pharmaceuticals and Increasing infectious diseases is fuelling the market the growth

Challenges:
High costs associated with the molecular biology enzymes

Restraints:
Low reimbursements in genetic testing may hamper the market growth

Opportunities:
Rising activities in research and developments and Increasing number of hereditary disorders

Market Leaders and their expansionary development strategies
On 5 January 2022, Thermo Fisher Scientific Inc., the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, announced that Thermo Fisher completed its acquisition of PeproTech
On 18 March 2021 Creative Enzymes is a professional enzyme provider located in New York, USA, which always hammers at researches and trials in order to provide customers with various enzyme products as many as possible. With the aim of developing efficient enzyme tools to better support customer’s research, after hard work and dedication, Creative Enzymes is very excited to announce the launch of the newly-developed molecular tools. The company wanted to make the new website faster, easier to navigate, and more user-friendly.


Key Target Audience
Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Polymerases
  • Ligases
  • Restriction Endonucleases
  • Reverse Transcriptases
  • Phosphatases
  • Proteases and Proteinases
  • Other Enzymes
By Application
  • PCR
  • Sequencing
  • Cloning
  • Epigenetics
  • Restriction Digestion
  • Synthetic Biology
  • Other Applications
By End users
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology companies
  • Hospitals & Diagnostic Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising usage of protein and reagents in pharmaceuticals
      • 3.2.2. Increasing infectious diseases is fuelling the market the growth
    • 3.3. Market Challenges
      • 3.3.1. High costs associated with the molecular biology enzymes
    • 3.4. Market Trends
      • 3.4.1. Technological advancements in life sciences
      • 3.4.2. Rising implementation of biotechnology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Biology Enzymes, by Type, Application, End users and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Molecular Biology Enzymes (Value)
      • 5.2.1. Global Molecular Biology Enzymes by: Type (Value)
        • 5.2.1.1. Polymerases
        • 5.2.1.2. Ligases
        • 5.2.1.3. Restriction Endonucleases
        • 5.2.1.4. Reverse Transcriptases
        • 5.2.1.5. Phosphatases
        • 5.2.1.6. Proteases and Proteinases
        • 5.2.1.7. Other Enzymes
      • 5.2.2. Global Molecular Biology Enzymes by: Application (Value)
        • 5.2.2.1. PCR
        • 5.2.2.2. Sequencing
        • 5.2.2.3. Cloning
        • 5.2.2.4. Epigenetics
        • 5.2.2.5. Restriction Digestion
        • 5.2.2.6. Synthetic Biology
        • 5.2.2.7. Other Applications
      • 5.2.3. Global Molecular Biology Enzymes by: End users (Value)
        • 5.2.3.1. Academic & Research Institutes
        • 5.2.3.2. Pharmaceutical & Biotechnology companies
        • 5.2.3.3. Hospitals & Diagnostic Centers
      • 5.2.4. Global Molecular Biology Enzymes Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Molecular Biology Enzymes (Price)
      • 5.3.1. Global Molecular Biology Enzymes by: Type (Price)
  • 6. Molecular Biology Enzymes: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. New England Biolabs (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Promega (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Illumina (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Agilent Technologies (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. F. Hoffmann-la Roche (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Takara Bio (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. QIAGEN N.V. (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Becton Dickinson (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Creative Enzymes (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Molecular Biology Enzymes Sale, by Type, Application, End users and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Molecular Biology Enzymes (Value)
      • 7.2.1. Global Molecular Biology Enzymes by: Type (Value)
        • 7.2.1.1. Polymerases
        • 7.2.1.2. Ligases
        • 7.2.1.3. Restriction Endonucleases
        • 7.2.1.4. Reverse Transcriptases
        • 7.2.1.5. Phosphatases
        • 7.2.1.6. Proteases and Proteinases
        • 7.2.1.7. Other Enzymes
      • 7.2.2. Global Molecular Biology Enzymes by: Application (Value)
        • 7.2.2.1. PCR
        • 7.2.2.2. Sequencing
        • 7.2.2.3. Cloning
        • 7.2.2.4. Epigenetics
        • 7.2.2.5. Restriction Digestion
        • 7.2.2.6. Synthetic Biology
        • 7.2.2.7. Other Applications
      • 7.2.3. Global Molecular Biology Enzymes by: End users (Value)
        • 7.2.3.1. Academic & Research Institutes
        • 7.2.3.2. Pharmaceutical & Biotechnology companies
        • 7.2.3.3. Hospitals & Diagnostic Centers
      • 7.2.4. Global Molecular Biology Enzymes Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Molecular Biology Enzymes (Price)
      • 7.3.1. Global Molecular Biology Enzymes by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Biology Enzymes: by Type(USD Million)
  • Table 2. Molecular Biology Enzymes Polymerases , by Region USD Million (2018-2023)
  • Table 3. Molecular Biology Enzymes Ligases , by Region USD Million (2018-2023)
  • Table 4. Molecular Biology Enzymes Restriction Endonucleases , by Region USD Million (2018-2023)
  • Table 5. Molecular Biology Enzymes Reverse Transcriptases , by Region USD Million (2018-2023)
  • Table 6. Molecular Biology Enzymes Phosphatases , by Region USD Million (2018-2023)
  • Table 7. Molecular Biology Enzymes Proteases and Proteinases , by Region USD Million (2018-2023)
  • Table 8. Molecular Biology Enzymes Other Enzymes , by Region USD Million (2018-2023)
  • Table 9. Molecular Biology Enzymes: by Application(USD Million)
  • Table 10. Molecular Biology Enzymes PCR , by Region USD Million (2018-2023)
  • Table 11. Molecular Biology Enzymes Sequencing , by Region USD Million (2018-2023)
  • Table 12. Molecular Biology Enzymes Cloning , by Region USD Million (2018-2023)
  • Table 13. Molecular Biology Enzymes Epigenetics , by Region USD Million (2018-2023)
  • Table 14. Molecular Biology Enzymes Restriction Digestion , by Region USD Million (2018-2023)
  • Table 15. Molecular Biology Enzymes Synthetic Biology , by Region USD Million (2018-2023)
  • Table 16. Molecular Biology Enzymes Other Applications , by Region USD Million (2018-2023)
  • Table 17. Molecular Biology Enzymes: by End users(USD Million)
  • Table 18. Molecular Biology Enzymes Academic & Research Institutes , by Region USD Million (2018-2023)
  • Table 19. Molecular Biology Enzymes Pharmaceutical & Biotechnology companies , by Region USD Million (2018-2023)
  • Table 20. Molecular Biology Enzymes Hospitals & Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 21. South America Molecular Biology Enzymes, by Country USD Million (2018-2023)
  • Table 22. South America Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 23. South America Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 24. South America Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 25. Brazil Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 26. Brazil Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 27. Brazil Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 28. Argentina Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 29. Argentina Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 30. Argentina Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 31. Rest of South America Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 32. Rest of South America Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 33. Rest of South America Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 34. Asia Pacific Molecular Biology Enzymes, by Country USD Million (2018-2023)
  • Table 35. Asia Pacific Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 36. Asia Pacific Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 37. Asia Pacific Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 38. China Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 39. China Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 40. China Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 41. Japan Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 42. Japan Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 43. Japan Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 44. India Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 45. India Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 46. India Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 47. South Korea Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 48. South Korea Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 49. South Korea Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 50. Taiwan Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 51. Taiwan Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 52. Taiwan Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 53. Australia Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 54. Australia Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 55. Australia Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 58. Rest of Asia-Pacific Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 59. Europe Molecular Biology Enzymes, by Country USD Million (2018-2023)
  • Table 60. Europe Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 61. Europe Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 62. Europe Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 63. Germany Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 64. Germany Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 65. Germany Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 66. France Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 67. France Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 68. France Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 69. Italy Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 70. Italy Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 71. Italy Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 72. United Kingdom Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 73. United Kingdom Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 74. United Kingdom Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 75. Netherlands Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 76. Netherlands Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 77. Netherlands Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 78. Rest of Europe Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 79. Rest of Europe Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 80. Rest of Europe Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 81. MEA Molecular Biology Enzymes, by Country USD Million (2018-2023)
  • Table 82. MEA Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 83. MEA Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 84. MEA Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 85. Middle East Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 86. Middle East Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 87. Middle East Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 88. Africa Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 89. Africa Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 90. Africa Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 91. North America Molecular Biology Enzymes, by Country USD Million (2018-2023)
  • Table 92. North America Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 93. North America Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 94. North America Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 95. United States Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 96. United States Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 97. United States Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 98. Canada Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 99. Canada Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 100. Canada Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 101. Mexico Molecular Biology Enzymes, by Type USD Million (2018-2023)
  • Table 102. Mexico Molecular Biology Enzymes, by Application USD Million (2018-2023)
  • Table 103. Mexico Molecular Biology Enzymes, by End users USD Million (2018-2023)
  • Table 104. Molecular Biology Enzymes: by Type(USD/Units)
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Molecular Biology Enzymes: by Type(USD Million)
  • Table 117. Molecular Biology Enzymes Polymerases , by Region USD Million (2025-2030)
  • Table 118. Molecular Biology Enzymes Ligases , by Region USD Million (2025-2030)
  • Table 119. Molecular Biology Enzymes Restriction Endonucleases , by Region USD Million (2025-2030)
  • Table 120. Molecular Biology Enzymes Reverse Transcriptases , by Region USD Million (2025-2030)
  • Table 121. Molecular Biology Enzymes Phosphatases , by Region USD Million (2025-2030)
  • Table 122. Molecular Biology Enzymes Proteases and Proteinases , by Region USD Million (2025-2030)
  • Table 123. Molecular Biology Enzymes Other Enzymes , by Region USD Million (2025-2030)
  • Table 124. Molecular Biology Enzymes: by Application(USD Million)
  • Table 125. Molecular Biology Enzymes PCR , by Region USD Million (2025-2030)
  • Table 126. Molecular Biology Enzymes Sequencing , by Region USD Million (2025-2030)
  • Table 127. Molecular Biology Enzymes Cloning , by Region USD Million (2025-2030)
  • Table 128. Molecular Biology Enzymes Epigenetics , by Region USD Million (2025-2030)
  • Table 129. Molecular Biology Enzymes Restriction Digestion , by Region USD Million (2025-2030)
  • Table 130. Molecular Biology Enzymes Synthetic Biology , by Region USD Million (2025-2030)
  • Table 131. Molecular Biology Enzymes Other Applications , by Region USD Million (2025-2030)
  • Table 132. Molecular Biology Enzymes: by End users(USD Million)
  • Table 133. Molecular Biology Enzymes Academic & Research Institutes , by Region USD Million (2025-2030)
  • Table 134. Molecular Biology Enzymes Pharmaceutical & Biotechnology companies , by Region USD Million (2025-2030)
  • Table 135. Molecular Biology Enzymes Hospitals & Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 136. South America Molecular Biology Enzymes, by Country USD Million (2025-2030)
  • Table 137. South America Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 138. South America Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 139. South America Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 140. Brazil Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 141. Brazil Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 142. Brazil Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 143. Argentina Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 144. Argentina Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 145. Argentina Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 146. Rest of South America Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 147. Rest of South America Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 148. Rest of South America Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 149. Asia Pacific Molecular Biology Enzymes, by Country USD Million (2025-2030)
  • Table 150. Asia Pacific Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 151. Asia Pacific Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 152. Asia Pacific Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 153. China Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 154. China Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 155. China Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 156. Japan Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 157. Japan Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 158. Japan Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 159. India Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 160. India Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 161. India Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 162. South Korea Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 163. South Korea Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 164. South Korea Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 165. Taiwan Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 166. Taiwan Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 167. Taiwan Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 168. Australia Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 169. Australia Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 170. Australia Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 171. Rest of Asia-Pacific Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 172. Rest of Asia-Pacific Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 173. Rest of Asia-Pacific Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 174. Europe Molecular Biology Enzymes, by Country USD Million (2025-2030)
  • Table 175. Europe Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 176. Europe Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 177. Europe Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 178. Germany Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 179. Germany Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 180. Germany Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 181. France Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 182. France Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 183. France Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 184. Italy Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 185. Italy Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 186. Italy Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 187. United Kingdom Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 188. United Kingdom Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 189. United Kingdom Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 190. Netherlands Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 191. Netherlands Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 192. Netherlands Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 193. Rest of Europe Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 194. Rest of Europe Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 195. Rest of Europe Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 196. MEA Molecular Biology Enzymes, by Country USD Million (2025-2030)
  • Table 197. MEA Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 198. MEA Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 199. MEA Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 200. Middle East Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 201. Middle East Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 202. Middle East Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 203. Africa Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 204. Africa Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 205. Africa Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 206. North America Molecular Biology Enzymes, by Country USD Million (2025-2030)
  • Table 207. North America Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 208. North America Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 209. North America Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 210. United States Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 211. United States Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 212. United States Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 213. Canada Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 214. Canada Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 215. Canada Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 216. Mexico Molecular Biology Enzymes, by Type USD Million (2025-2030)
  • Table 217. Mexico Molecular Biology Enzymes, by Application USD Million (2025-2030)
  • Table 218. Mexico Molecular Biology Enzymes, by End users USD Million (2025-2030)
  • Table 219. Molecular Biology Enzymes: by Type(USD/Units)
  • Table 220. Research Programs/Design for This Report
  • Table 221. Key Data Information from Secondary Sources
  • Table 222. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Biology Enzymes: by Type USD Million (2018-2023)
  • Figure 5. Global Molecular Biology Enzymes: by Application USD Million (2018-2023)
  • Figure 6. Global Molecular Biology Enzymes: by End users USD Million (2018-2023)
  • Figure 7. South America Molecular Biology Enzymes Share (%), by Country
  • Figure 8. Asia Pacific Molecular Biology Enzymes Share (%), by Country
  • Figure 9. Europe Molecular Biology Enzymes Share (%), by Country
  • Figure 10. MEA Molecular Biology Enzymes Share (%), by Country
  • Figure 11. North America Molecular Biology Enzymes Share (%), by Country
  • Figure 12. Global Molecular Biology Enzymes: by Type USD/Units (2018-2023)
  • Figure 13. Global Molecular Biology Enzymes share by Players 2023 (%)
  • Figure 14. Global Molecular Biology Enzymes share by Players (Top 3) 2023(%)
  • Figure 15. Global Molecular Biology Enzymes share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 19. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 20. Merck (United States) Revenue: by Geography 2023
  • Figure 21. New England Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 22. New England Biolabs (United States) Revenue: by Geography 2023
  • Figure 23. Promega (United States) Revenue, Net Income and Gross profit
  • Figure 24. Promega (United States) Revenue: by Geography 2023
  • Figure 25. Illumina (United States) Revenue, Net Income and Gross profit
  • Figure 26. Illumina (United States) Revenue: by Geography 2023
  • Figure 27. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 28. Agilent Technologies (United States) Revenue: by Geography 2023
  • Figure 29. F. Hoffmann-la Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. F. Hoffmann-la Roche (Switzerland) Revenue: by Geography 2023
  • Figure 31. Takara Bio (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Takara Bio (Japan) Revenue: by Geography 2023
  • Figure 33. QIAGEN N.V. (Germany) Revenue, Net Income and Gross profit
  • Figure 34. QIAGEN N.V. (Germany) Revenue: by Geography 2023
  • Figure 35. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 36. Becton Dickinson (United States) Revenue: by Geography 2023
  • Figure 37. Creative Enzymes (United States) Revenue, Net Income and Gross profit
  • Figure 38. Creative Enzymes (United States) Revenue: by Geography 2023
  • Figure 39. Global Molecular Biology Enzymes: by Type USD Million (2025-2030)
  • Figure 40. Global Molecular Biology Enzymes: by Application USD Million (2025-2030)
  • Figure 41. Global Molecular Biology Enzymes: by End users USD Million (2025-2030)
  • Figure 42. South America Molecular Biology Enzymes Share (%), by Country
  • Figure 43. Asia Pacific Molecular Biology Enzymes Share (%), by Country
  • Figure 44. Europe Molecular Biology Enzymes Share (%), by Country
  • Figure 45. MEA Molecular Biology Enzymes Share (%), by Country
  • Figure 46. North America Molecular Biology Enzymes Share (%), by Country
  • Figure 47. Global Molecular Biology Enzymes: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • Merck (United States)
  • New England Biolabs (United States)
  • Promega (United States)
  • Illumina (United States)
  • Agilent Technologies (United States)
  • F. Hoffmann-la Roche (Switzerland)
  • Takara Bio (Japan)
  • QIAGEN N.V. (Germany)
  • Becton Dickinson (United States)
  • Creative Enzymes (United States)
Additional players considered in the study are as follows:
Sunsun (China) , Toyobo (Japan)
Select User Access Type

Key Highlights of Report


Apr 2024 198 Pages 51 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific (United States), Merck (United States), New England Biolabs (United States), Promega (United States), Illumina (United States), Agilent Technologies (United States), F. Hoffmann-la Roche (Switzerland), Takara Bio (Japan), QIAGEN N.V. (Germany), Becton Dickinson (United States) and Creative Enzymes (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological advancements in life sciences " is seen as one of major influencing trends for Molecular Biology Enzymes Market during projected period 2023-2030.
The Molecular Biology Enzymes market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Molecular Biology Enzymes Report?